Toggle navigation
Drugs
Combinations
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Tacrolimus Capsules
Indications and Reactions:
Role
Indications
Reactions
Primary
Lupus Nephritis
17.8%
Product Used For Unknown Indication
16.9%
Prophylaxis
16.0%
Renal Transplant
8.0%
Plasma Cell Myeloma
7.6%
Liver Transplant
6.9%
Rheumatoid Arthritis
2.7%
Hypertension
2.4%
Insomnia
2.4%
Myasthenia Gravis
2.4%
Colitis Ulcerative
2.2%
Skin Ulcer
2.0%
Stem Cell Transplant
1.8%
Systemic Lupus Erythematosus
1.8%
Constipation
1.6%
Hyperlipidaemia
1.6%
Immunosuppression
1.6%
Schizophrenia
1.6%
Bone Marrow Transplant
1.3%
Prophylaxis Against Graft Versus Host Disease
1.3%
Death
51.9%
Off Label Use
5.1%
Posterior Reversible Encephalopathy Syndrome
5.1%
Renal Disorder
5.1%
Pneumonia
3.8%
Schizophrenia
3.8%
Transplant Failure
3.8%
Urinary Tract Infection
3.8%
Upper Respiratory Tract Inflammation
2.5%
Ureteric Stenosis
2.5%
Angioimmunoblastic T-cell Lymphoma Recurrent
1.3%
Biliary Cirrhosis Primary
1.3%
Blood Creatinine Increased
1.3%
Blood Pressure Increased
1.3%
Cholecystitis
1.3%
Diarrhoea
1.3%
Drug Level Fluctuating
1.3%
Duodenal Ulcer
1.3%
General Physical Health Deterioration
1.3%
Glomerular Filtration Rate Decreased
1.3%
Secondary
Prophylaxis
19.9%
Lupus Nephritis
18.1%
Colitis Ulcerative
15.9%
Product Used For Unknown Indication
12.1%
Skin Ulcer
6.7%
Bone Marrow Transplant
3.2%
Graft Versus Host Disease
3.2%
Systemic Lupus Erythematosus
3.0%
Hyperlipidaemia
2.9%
Herpes Zoster
1.9%
Mixed Connective Tissue Disease
1.9%
Myasthenia Gravis
1.9%
Renal Transplant
1.6%
Insomnia
1.4%
Upper Respiratory Tract Inflammation
1.3%
Constipation
1.1%
Schizophrenia
1.1%
Arthralgia
1.0%
Asthma
1.0%
Calculus Ureteric
1.0%
Tremor
18.1%
Renal Disorder
10.8%
Urinary Tract Infection
10.8%
Liver Disorder
7.2%
Systemic Lupus Erythematosus
7.2%
Wrong Technique In Drug Usage Process
6.0%
Cholecystitis
4.8%
General Physical Health Deterioration
4.8%
No Adverse Event
4.8%
Muscular Weakness
3.6%
Schizophrenia
3.6%
Tinea Manuum
3.6%
Duodenal Ulcer
2.4%
Influenza
2.4%
Nephrolithiasis
2.4%
Upper Respiratory Tract Inflammation
2.4%
Angioimmunoblastic T-cell Lymphoma Recurrent
1.2%
Blood Pressure Increased
1.2%
Diarrhoea
1.2%
Drug Level Fluctuating
1.2%
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Drug Data
Drugs
Combinations